US Stocks
/
Janux Therapeutics, Inc. Share Price
Janux Therapeutics, Inc. Share Price

Janux Therapeutics, Inc. Share Price

NASDAQ: JANX | Small Cap
$18.39
-$0.12 (-0.65%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Janux Therapeutics, Inc. Stock Performance

Open
$18.54
Prev. Close
$18.52
Circuit Range
N/A
Day Range
$18.33 - $19.16
Year Range
$12.14 - $35.24
Volume
1,00,155
Average Traded
$18.80

Janux Therapeutics, Inc. Share Price Today

As of 11 October 2026, Janux Therapeutics, Inc.'s share price is $18.39. The stock opened at $18.54, compared to its previous close of $18.52. During today's trading session, Janux Therapeutics, Inc.'s share price traded between $18.33 and $19.16, with an average price of $18.74. Over the past 52 weeks, the stock has recorded a high of $35.24 and a low of $12.14. In terms of performance, Janux Therapeutics, Inc.'s share price has risen by 28.10% over the last six months and is down 35.97% on a year-on-year basis.

Janux Therapeutics, Inc. Share Price Chart

$18.33$19.16
L
Show Current Price
H

Janux Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.14B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.68
Revenue (TTM)
$10.00B
Return On Equity (TTM)
-11.06%
Profit Margin
-1136.30%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
9.63%

Janux Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$10.00$0.00$3.73$10.27
Net Profit-$24.31-$31.95-$24.36-$21.97
Net Profit Margin-243.10%N/A-653.08%-213.92%
Income ChangeN/A-31.43%23.76%9.81%

Janux Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$8.61$8.08$10.59$10.00
Net Profit-$63.06-$58.29-$68.99-$113.63
Net Profit Margin-732.40%-721.41%-651.46%-1136.30%
Income ChangeN/A7.56%-18.36%-64.71%

About Janux Therapeutics, Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Janux Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$17.18
$18.39
+6.21%
Sep 2026
$18.23
$17.32
-7.73%
Aug 2026
$15.23
$18.77
+23.94%
Jul 2026
$15.36
$15.14
-1.30%
Jun 2026
$14.50
$15.34
+5.14%
May 2026
$14.20
$14.59
+1.60%
Apr 2026
$14.11
$14.36
+3.38%
Mar 2026
$13.40
$13.89
+1.91%
Feb 2026
$13.61
$13.63
-0.44%
Jan 2026
$13.75
$13.69
-0.80%
Dec 2025
$33.70
$13.80
-59.59%
Nov 2025
$28.32
$34.15
+18.87%

JANX Share Price FAQs

What is Janux Therapeutics, Inc. share price today?

chevron-up
Janux Therapeutics, Inc. share price today is $18.39 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Janux Therapeutics, Inc. stock?

chevron-up
The 52 week high of Janux Therapeutics, Inc. stock is $35.24, while the 52 week low is $12.14 as of 10 Oct '26.

What is JANX's market capitalisation today?

chevron-up
JANX market capitalisation is $1.14B as of October 11, 2026, at 2:05 am IST.

What is JANX's net income for the last quarter?

chevron-up
JANX's net income for the last quarter is -21.97B USD.

What is the 5 year returns of JANX?

chevron-up
The 5 year returns of JANX is -24.46% as on 10 Oct '26.

What is the high & low stock price of JANX today?

chevron-up
JANX stock price hit a high of $19.16 and low of $18.33 as of 10 Oct '26.

Can I buy JANX shares in India?

chevron-up
Yes. You can buy JANX in India by opening an international trading account.